Randomised controlled trial of two brief interventions against long-term benzodiazepine use: Cost-effectiveness

By Godfrey Christine   Heather Nick   Bowie Alison   Brodie Jennifer   Parrott Steve   Ashton Heather   McAvoy Brian  

Addiction Research and Theory, Vol. 16, Iss. 4, 2008-08 ,pp. : 309-317

Informa Healthcare

Access to resources Recommend Favorite

A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment

By Tarride Jean-Eric   Hopkins Robert   Blackhouse Gord   Bowen James M.   Bischof Matthias   >   O'Reilly Daria   Xie Feng   Goeree Ron  

PharmacoEconomics, Vol. 28, Iss. 4, 2010-04 ,pp. : 255-277

Adis International

Access to resources Recommend Favorite

The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia

By DiSantostefano Rachael L.   Biddle Andrea K.  

PharmacoEconomics, Vol. 24, Iss. 2, 2006-01 ,pp. : 171-191

Adis International

Access to resources Recommend Favorite

Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure: An Individual Patient-Based Simulation Model

By Yao Guiqing  

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 879-889

Adis International

Access to resources Recommend Favorite

Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of Recurrence

By Hall Peter S.   Hulme Claire   McCabe Christopher   Oluboyede Yemi   Round Jeff   Cameron David A.  

PharmacoEconomics, Vol. 29, Iss. 5, 2011-05 ,pp. : 415-432

Adis International

Access to resources Recommend Favorite